Responses
Inflammatory bowel disease
Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 18 April 2016
- Published on: 18 April 2016Synbiotic therapy for ulcerative colitisShow More
Dear Editor,
We read with interest the article by Furrie et al. [1]. Whilst we believe this approach represents a very interesting advance in our understanding of aspects of the mucosal response to synbiotic therapy in UC, we would like to raise some questions about the design of the study, which relate in particular to the conclusion that the synbiotic cocktail produces some improvement in disease activity in UC....
Conflict of Interest:
None declared.